Skip to main content

Table 3 Comparison of serum bone turnovers markers at 12 weeks after hysterectomy with bilateral oophorectomy between the hormone treatment and no treatment groups

From: Effects of early estradiol valerate administration on bone turnover markers in surgically induced menopausal women

Bone turnover markers

Hormone treatment group (n = 21)

No treatment group (n = 20)

p-value

CTX levels (ng/ml)

0.21 (0.14–0.34)

0.47 (0.28–0.65)

 < 0.001

P1NP levels (ng/ml)

42.41 (31.42–63.61)

63.63 (54.98–80.45)

0.004

  1. Data was presented as median (IQR) and analyzed with ANCOVA (adjusted for age)